Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1992 Jun 6;304(6840):1501–1504. doi: 10.1136/bmj.304.6840.1501

Ovarian and cervical cancer.

C Williams 1
PMCID: PMC1882244  PMID: 1611377

Abstract

Death rates from cervical cancer have already fallen this century and for patients with invasive cervical cancer five year survival rates are greater than for most solid tumours. Better screening for premalignant changes may further reduce the incidence of invasive cancer; indeed, it has been claimed that the reduction in mortality could be as high as 90%, though estimates of screening efficacy have varied greatly. For those with advanced invasive carcinoma neoadjuvant chemotherapy may reduce the risk of relapse and improve survival.

Full text

PDF
1501

Images in this article

1501FIG 2
on p.1501
1504p1504-a
on p.1504

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Averette H. E., LaPlatney D. R., Little W. A. Current role of radical hysterectomy as primary therapy for invasive carcinoma of the cervix. Am J Obstet Gynecol. 1969 Sep 1;105(1):79–89. doi: 10.1016/0002-9378(69)90160-4. [DOI] [PubMed] [Google Scholar]
  2. Buxton E. J., Meanwell C. A., Hilton C., Mould J. J., Spooner D., Chetiyawardana A., Latief T., Paterson M., Redman C. W., Luesley D. M. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst. 1989 Mar 1;81(5):359–361. doi: 10.1093/jnci/81.5.359. [DOI] [PubMed] [Google Scholar]
  3. Cullhed S. Carcinoma cervicis uteri stages I and IIa. Treatment - histopathology - prognosis. Acta Obstet Gynecol Scand Suppl. 1978;75:1–149. [PubMed] [Google Scholar]
  4. Dembo A. J., Bush R. S., Beale F. A., Bean H. A., Pringle J. F., Sturgeon J. F. The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations. Cancer Treat Rep. 1979 Feb;63(2):249–254. [PubMed] [Google Scholar]
  5. Heintz A. P., Van Oosterom A. T., Trimbos J. B., Schaberg A., Van der Velde E. A., Nooy M. The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis. Gynecol Oncol. 1988 Jul;30(3):347–358. doi: 10.1016/0090-8258(88)90249-1. [DOI] [PubMed] [Google Scholar]
  6. Jampolis S., Andras E. J., Fletcher G. H. Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology. 1975 Jun;115(3):681–685. doi: 10.1148/15.3.681. [DOI] [PubMed] [Google Scholar]
  7. Lynch H. T., Bewtra C., Lynch J. F. Familial ovarian carcinoma. Clinical nuances. Am J Med. 1986 Dec;81(6):1073–1076. doi: 10.1016/0002-9343(86)90411-0. [DOI] [PubMed] [Google Scholar]
  8. Morley G. W., Seski J. C. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol. 1976 Dec 1;126(7):785–798. doi: 10.1016/0002-9378(76)90668-2. [DOI] [PubMed] [Google Scholar]
  9. Perez C. A., Camel H. M., Kao M. S., Askin F. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: preliminary analysis of failures and complications. Cancer. 1980 Jun 1;45(11):2759–2768. doi: 10.1002/1097-0142(19800601)45:11<2759::aid-cncr2820451110>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  10. Richardson G. S., Scully R. E., Nikrui N., Nelson J. H., Jr Common epithelial cancer of the ovary (2). N Engl J Med. 1985 Feb 14;312(7):415–424. doi: 10.1056/NEJM198502143120706. [DOI] [PubMed] [Google Scholar]
  11. Smith J. P., Rutledge F. N., Delclos L. Postoperative treatment of early cancer of the ovary: a random trial between postoperative irradiation and chemotherapy. Natl Cancer Inst Monogr. 1975 Oct;42:149–153. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES